| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2be1effe2aad8610d58162b6e1f93fb |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-056 |
| filingDate |
2016-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2022-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_842483dad0c307f09cace4c653aeafcc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10f26eb5bac891118df20244ff042779
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34b0d031824862c0661c45d00ddddeae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a5becabe894eba3cf0cd2fff073e696
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_059d7af44010227aa14e165e35de6d64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8975b3f5f5cdc6744cd81c2892567516
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd11dd82446f9808c6a173cccf8e1725 |
| publicationDate |
2022-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2921500-T3 |
| titleOfInvention |
1,1'-sulfanediyl-di-beta-d-galactopyranosides as inhibitors of galectins |
| abstract |
The present invention relates to a compound of the general formula (1). wherein A is selected from a group of formula 2. B is selected from a group of formula 3. The compound of formula (1) is suitable for use in a method of treating a galectin binding related disorder, such as galectin -3 to a ligand in a mammal, such as a human. (Automatic translation with Google Translate, without legal value) |
| priorityDate |
2015-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |